NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Max Healthcare Institute Sees Modest Profit Rise Amid Capacity Expansion

Max Healthcare Institute reported a 3 percent year-on-year rise in March-quarter net profit, as steady volume growth and higher patient throughput helped offset margin pressure from aggressive hiring and capacity expansion. The hospital chain posted a Q4FY26 profit of Rs. 387 crore, with revenue rising 10 percent to Rs 2,664 crore, driven primarily by higher occupied bed days and stable occupancy across its network.

QuarterRevenue (in Rs. crore)Net Profit (in Rs. crore)
Q4FY252,420378
Q4FY262,664387

Growth was driven by an 8 percent increase in occupied bed days, while bed occupancy remained stable at 75%, underlining resilient demand. Operating performance remained steady, with EBITDA rising 8 percent to Rs 682 crore, though margins softened to 26.8 percent from 27.2 percent a year earlier. The decline was largely due to higher clinician costs, which increased as the company added talent to support upcoming capacity additions.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Max is entering a phase of capacity-led expansion, where volumes remain strong but profitability is being tempered by upfront investments in people and infrastructure. The company's ability to sustain utilisation while ramping up new beds will determine the pace of margin recovery ahead. On the operating metrics front, realisations were largely stable. Average revenue per occupied bed (ARPOB) edged up to Rs 77,900, compared with Rs 77,100 a year ago, indicating limited pricing-led growth. Meanwhile, average length of stay (ALOS) rose to about 4.2 days, reflecting the impact of new capacity coming on stream and changes in case mix.

The quarter also marked continued progress on the company's expansion strategy. Max has rolled out around 20 percent additional brownfield capacity over the past six months, with another 10 percent expected to be added by the end of the year, including new facilities in key urban markets. For full year, Max reported revenue of Rs 10,538 crore, up 16 percent year-on-year, and net profit of Rs 1,631 crore, up 22 percent, even as EBITDA margins eased to 26.2 percent from 26.8 percent a year earlier amid expansion-led cost pressures.

Key additions include a 400-bed tower at Max Smart Hospital in Delhi, a fully operational 160-bed tower in Mohali, and phased ramp-up at the Nanavati-Max facility in Mumbai. The company also strengthened its geographic footprint by acquiring a controlling 58.28 percent stake in Kalinga Hospital in Bhubaneswar, while approving a Rs 1,400 crore greenfield hospital in Lucknow.

Investor Takeaway

Max Healthcare's Q4 profit growth indicates resilient demand, but profitability is being tempered by capacity expansion.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.